Post by account_disabled on Dec 26, 2023 6:30:42 GMT
Luye Pharma Group held a special signing ceremony under the initiative “We Care About Mental Health”, marking the beginning of a new strategic partnership in three markets across Asia. On this occasion, Luye Pharma granted rights to the company. Alvogen Korea Co. Ltd., Zuellig Pharma Ltd. and DKSH (Thailand) Ltd. in the distribution and marketing of Seroquel(R) (quetiapine fumarate) immediate-release formula) and Seroquel After signing All parties joined forces under the "We Care About Mental Health" project to raise awareness and provide assistance to patients, doctors, and the public health system. in supporting needs that have not yet been met This is especially true in challenging situations like the COVID-19 pandemic.
Mental illnesses such as schizophrenia, bipolar disorder, depression, and anxiety disorders It is a challenging problem for patients, doctors, and public health systems in every country. Statistics from the Telegram Number Data World Health Organization (WHO) indicate that people with schizophrenia account for approximately 1% of the world's population. Bipolar disorder accounts for approximately 2-3% of people and may be as high as 5% in some countries and regions. The number of patients around the world is likely to continue to increase, causing harm to both patients and society. It was found that schizophrenia patients have a death rate 2-3 times higher than the general population and their average life expectancy is reduced by 10-20 years. Deaths from suicide among patients with bipolar disorder are also higher. is at a high level and may be more than 20 times higher than in the general population, especially when untreated. In addition, the impact on patients and their loved ones is more severe. Due to the COVID-19 outbreak situation The time to act is now.
The “We Care About Mental Health” project is designed to raise awareness of the importance of mental health issues facing society today. With the goal of building participation across multiple regions, Luye Pharma and its partners There will be lectures both online and offline by mental health experts. To educate the public and raise awareness about the problems of mental illness. “Mental health is a very serious global public health problem. and requires a sustained and united response from all of us,” said Andy Siow, Regional Director, Asia Pacific, Luye Pharma (International). “Partnering with three leading companies in the region gives us confidence that the project will deliver.” We Care About Mental Health” will be able to increase knowledge, understanding and awareness of mental health issues. It also provides insight into treatment options. and reinforce the need for patients to seek treatment.
Mental illnesses such as schizophrenia, bipolar disorder, depression, and anxiety disorders It is a challenging problem for patients, doctors, and public health systems in every country. Statistics from the Telegram Number Data World Health Organization (WHO) indicate that people with schizophrenia account for approximately 1% of the world's population. Bipolar disorder accounts for approximately 2-3% of people and may be as high as 5% in some countries and regions. The number of patients around the world is likely to continue to increase, causing harm to both patients and society. It was found that schizophrenia patients have a death rate 2-3 times higher than the general population and their average life expectancy is reduced by 10-20 years. Deaths from suicide among patients with bipolar disorder are also higher. is at a high level and may be more than 20 times higher than in the general population, especially when untreated. In addition, the impact on patients and their loved ones is more severe. Due to the COVID-19 outbreak situation The time to act is now.
The “We Care About Mental Health” project is designed to raise awareness of the importance of mental health issues facing society today. With the goal of building participation across multiple regions, Luye Pharma and its partners There will be lectures both online and offline by mental health experts. To educate the public and raise awareness about the problems of mental illness. “Mental health is a very serious global public health problem. and requires a sustained and united response from all of us,” said Andy Siow, Regional Director, Asia Pacific, Luye Pharma (International). “Partnering with three leading companies in the region gives us confidence that the project will deliver.” We Care About Mental Health” will be able to increase knowledge, understanding and awareness of mental health issues. It also provides insight into treatment options. and reinforce the need for patients to seek treatment.